Related Experiment Video
Updated: Aug 26, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Heart Failure in Complex Congenital Heart Disease of the Adult
Anisa Chaudhry1, Julia Selwyn2, Elizabeth Adams1
1Division of Cardiovascular Medicine, Penn State Heart and Vascular Institute, Pennsylvania State University College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, 17033, USA.
Insights
Adult congenital heart disease (ACHD) patients with complex conditions are surviving longer. Advanced therapies, including new devices and heart transplantation, offer improved outcomes for heart failure in ACHD.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Heart Failure Management
Background:
- Adult congenital heart disease (ACHD) survival rates have improved, particularly for complex cases like single-ventricle/Fontan physiology and systemic right ventricle.
- Heart failure is an emerging concern in the growing ACHD population.
Purpose of the Study:
- To describe heart failure phenotypes in complex ACHD.
- To identify reversible causes of heart failure in ACHD.
- To discuss considerations for advanced therapies in ACHD.
Main Methods:
- Review of current literature on heart failure in ACHD.
- Analysis of emerging device-based technologies for heart failure.
- Evaluation of orthotopic heart transplant (OHT) in ACHD.
Main Results:
- Newer heart failure devices and technologies are increasingly being applied to the ACHD population.
- Addressing reversible causes of heart failure is a prerequisite for considering advanced therapies.
- Advanced therapies like device implantation and OHT can improve morbidity and mortality in complex ACHD.
Conclusions:
- Advanced therapies, including novel devices and OHT, should be carefully considered for end-stage heart failure in complex ACHD.
- These interventions hold potential for significant improvements in survival and quality of life for ACHD patients.
- A tailored approach is necessary for applying advanced therapies in the unique context of ACHD.
Purpose Of Review:
Adult congenital heart disease (ACHD) patients have demonstrated improved survival, especially those with severely complex disease, mainly single-ventricle/Fontan physiology and those with a systemic right ventricle. We describe the heart failure phenotypes of complex CHD, reversible causes for heart failure, and considerations for advanced therapy.
Recent Findings:
While initially marketed for application to patients with acquired causes for heart failure, newer devices and technologies have started to be used in the ACHD population. After reversible causes for heart failure in CHD are addressed, it is reasonable to consider use of new device-based technologies and orthotopic heart transplant (OHT) for end-stage disease. New heart failure technology and organ transplant should carefully be considered and applied in complex ACHD, where there may be significant improvement in morbidity and mortality.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Related Concept Videos
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction